EyeMove is a brand that specializes in online monitoring of Parkinson's disease through eye movements. Their innovative program, Eyemove, analyzes reaction time, eye movement duration, eye movement trajectories, and the correlation between eye movement and the brain. By detecting early signs of Parkinson's disease through eye movements, Eyemove aims to provide an accessible solution for the diagnosis and monitoring of central nervous system disorders such as Alzheimer's and Parkinson's, ADHD, Autism, and more.

The founders are committed to creating a user-friendly application that revolutionizes the early detection of neurological conditions. EyeMove also offers news updates and showcases the company's development history. They provide descriptions of clinical research and scientific articles by both Russian and international scientists, focusing on eye movement at the early stages of dementia-related diseases.

EyeMove's dedication to improving healthcare and assisting millions of people is highly appreciated by their clients, who value the accurate and timely detection of potential risks. Stay informed about their progress and receive important updates by subscribing to their monthly newsletter. EyeMove is pioneering the future of medicine and transforming healthcare for the better